Revolution Medicines, Inc. (RVMD)

NASDAQ: RVMD · Real-Time Price · USD

182.08

+3.91 (2.19%)

At close: Jun 26, 2026, 4:00 PM EDT

182.85

+0.77 (0.42%)

After-hours: Jun 26, 2026, 7:59 PM EDT

Revolution Medicines Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	440.94	383.75	543.06	696.15	161.41	108.5
Short-Term Investments	1,467	1,642	1,746	1,157	483.53	468.56
Cash & Short-Term Investments	1,908	2,026	2,289	1,853	644.94	577.05
Cash Growth	-9.25%	-11.52%	23.55%	187.31%	11.77%	30.93%
Accounts Receivable	-	-	-	1.25	4.67	5.93
Other Current Assets	59.83	49.36	38.33	25.07	10.57	6.79
Total Current Assets	1,968	2,075	2,328	1,879	660.19	589.77
Net Property, Plant & Equipment	161.37	165.28	141.82	100.01	73.74	71.24
Other Intangible Assets	55.8	55.8	56.67	57.74	58.81	59.88
Goodwill	14.61	14.61	14.61	14.61	14.61	14.61
Other Long-Term Assets	54.05	43.79	17.57	10.06	4.59	2.5
Total Assets	2,254	2,355	2,558	2,062	811.93	737.99
Accounts Payable	80.54	64.62	54.43	61.79	21.31	14.06
Accrued Expenses	192.45	209.34	96.62	74.69	29.45	27.72
Current Portion of Leases	16.61	16.47	12.87	7.37	6.77	6.21
Unearned Revenue	-	-	-	-	4.46	12.36
Total Current Liabilities	289.6	290.42	163.91	143.85	61.98	60.35
Long-Term Leases	140.02	142.23	122.97	80.58	57.43	60.42
Other Long-Term Liabilities	324.2	290.02	6.75	11.09	7.33	14.65
Total Long-Term Liabilities	464.22	432.25	129.72	91.66	64.76	75.07
Total Liabilities	753.82	723.21	293.1	235.51	126.74	135.42
Common Stock	0.02	0.02	0.02	0.02	0.01	0.01
Additional Paid-in Capital	4,823	4,497	4,002	2,963	1,388	1,056
Accumulated Other Comprehensive Income	-0.62	3.24	1.32	0.54	-1.78	-0.38
Retained Earnings	-3,323	-2,869	-1,738	-1,138	-701.34	-452.64
Shareholders' Equity	1,500	1,631	2,265	1,826	685.19	602.57
Total Liabilities & Equity	2,254	2,355	2,558	2,062	811.93	737.99
Total Debt	156.63	158.7	135.84	87.94	64.21	66.63
Net Cash (Debt)	1,751	1,867	2,153	1,765	580.74	510.42
Net Cash Growth	-6.19%	-13.30%	22.01%	203.93%	13.78%	25.08%
Net Cash Per Share	9.07	9.82	12.84	15.60	7.20	7.01
Book Value	1,500	1,631	2,265	1,826	685.19	602.57
Book Value Per Share	7.77	8.58	13.50	16.14	8.50	8.28
Tangible Book Value	1,430	1,561	2,194	1,754	611.77	528.08
Tangible Book Value Per Share	7.40	8.21	13.08	15.50	7.59	7.25

SEC Filings: 10-K · 10-Q